Literature DB >> 31228407

Exoskeletons for Personal Use After Spinal Cord Injury.

Casey Kandilakis1, Elizabeth Sasso-Lance2.   

Abstract

Before the development of robotic exoskeletons, mobility options beyond a wheelchair were very limited for most people lacking leg movement due to spinal cord injury (SCI). Over the years, robotic exoskeletons have become more widely available and now have the potential to be successfully used for personal use at home and in the community. However, it is important that users set realistic expectations. The features and capabilities of each robotic exoskeleton differ, and how exoskeletons are used may vary greatly between individuals. Robotic exoskeletons can allow individuals with SCI with varying levels of injury to safely and functionally walk for personal mobility or exercise. The following special communication will discuss important considerations surrounding exoskeleton use including feasibility, safety, cost, speed, and potential health benefits of using an exoskeleton for everyday life for people with SCI.
Copyright © 2019 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Exoskeleton device; Rehabilitation; Spinal cord injuries

Year:  2019        PMID: 31228407     DOI: 10.1016/j.apmr.2019.05.028

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  8 in total

1.  Hellenic Spinal Cord Section of the Hellenic Society of Physical and Rehabilitation Medicine National Congress 2019, "Healthy, and long living after SCI" Proceedings. 13th-15th December 2019, Vellideio, Thessaloniki, Greece.

Authors: 
Journal:  J Musculoskelet Neuronal Interact       Date:  2019-12-01       Impact factor: 2.041

2.  TWIICE One powered exoskeleton: effect of design improvements on usability in daily life as measured by the performance in the CYBATHLON race.

Authors:  Tristan Vouga; Jemina Fasola; Romain Baud; Ali Reza Manzoori; Julien Pache; Mohamed Bouri
Journal:  J Neuroeng Rehabil       Date:  2022-06-27       Impact factor: 5.208

3.  Wearable Power-Assist Locomotor for Gait Reconstruction in Patients With Spinal Cord Injury: A Retrospective Study.

Authors:  Soichiro Koyama; Shigeo Tanabe; Takeshi Gotoh; Yuta Taguchi; Masaki Katoh; Eiichi Saitoh; Yohei Otaka; Satoshi Hirano
Journal:  Front Neurorobot       Date:  2022-02-18       Impact factor: 2.650

4.  Body Representation in Patients with Severe Spinal Cord Injury: A Pilot Study on the Promising Role of Powered Exoskeleton for Gait Training.

Authors:  Maria Grazia Maggio; Antonino Naro; Rosaria De Luca; Desiree Latella; Tina Balletta; Lory Caccamo; Giovanni Pioggia; Daniele Bruschetta; Rocco Salvatore Calabrò
Journal:  J Pers Med       Date:  2022-04-11

5.  Evaluation of safety and performance of the self balancing walking system Atalante in patients with complete motor spinal cord injury.

Authors:  Jacques Kerdraon; Jean Gabriel Previnaire; Maegan Tucker; Pauline Coignard; Willy Allegre; Emmanuel Knappen; Aaron Ames
Journal:  Spinal Cord Ser Cases       Date:  2021-08-04

6.  Robotic Exoskeleton Gait Training During Acute Stroke Inpatient Rehabilitation.

Authors:  Karen J Nolan; Kiran K Karunakaran; Kathleen Chervin; Michael R Monfett; Radhika K Bapineedu; Neil N Jasey; Mooyeon Oh-Park
Journal:  Front Neurorobot       Date:  2020-10-30       Impact factor: 2.650

7.  Users with spinal cord injury experience of robotic Locomotor exoskeletons: a qualitative study of the benefits, limitations, and recommendations.

Authors:  Dominique Kinnett-Hopkins; Chaithanya K Mummidisetty; Linda Ehrlich-Jones; Deborah Crown; Rachel A Bond; Marc H Applebaum; Arun Jayaraman; Catherine Furbish; Gail Forrest; Edelle Field-Fote; Allen W Heinemann
Journal:  J Neuroeng Rehabil       Date:  2020-09-11       Impact factor: 4.262

8.  Exoskeleton home and community use in people with complete spinal cord injury.

Authors:  Rosanne B van Dijsseldonk; Ilse J W van Nes; Alexander C H Geurts; Noël L W Keijsers
Journal:  Sci Rep       Date:  2020-09-24       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.